Rapid Case Ascertainment (Andrew F. Olshan, Ph.D., Facility Director) Rapid case ascertainment is critical to the successful conduct of quality, population-based, epidemiologic studies, particularly case-control studies that incorporate molecular biology and biomarkers. Rapid ascertainment identifies potential cases prior to death or significant morbidity and allows timely interviewing and collection of biologic specimens. The objective of the UNC Lineberger Rapid Case Ascertainment Core is to support population-based epidemiology research by providing personnel for the rapid identification of new cancer cancers (selected sites) in North Carolina. The Core also helps coordinate: project IRB approvals at participating hospitals; reports to hospitals and tumor registrars, and activities among project investigators, the NC Central Cancer Registry, and related state committees. Working in collaboration with the NC Central Cancer Registry and UNC Lineberger investigators, core personnel facilitates case identification and data collection by traveling to and working with smaller, undermanned hospitals, located primarily in rural central and eastern North Carolina counties. These counties are racially and culturally diverse and located within several hours drive of the Research Triangle. Studies in these counties, rather than in the less diverse and more distant west-central and western counties, are more cost-effective and they have the population diversity and numbers to permit investigation of racial differences in cancer incidence and mortality. This is the first time that the UNC Lineberger is proposing Cancer Center Core Grant (CCSG) funding for the Rapid Case Ascertainment Core Facility. Over the past two years, the Center has used institutional funds to support these activities. In 1998, use totaled 2,129 new breast and colon cancer cases rapidly identified and 1,074 accruals to four NCI-funded projects representing two programs (Cancer Epidemiology, Breast Cancer). With the rapid growth of population-based studies, the Center is seeking CCSG support for this vital activity. CCSG funding of $41,727 will primarily support 0.80 FTE of the 3.00 circuit- riding data coordinators in the core resource. CCSG funding will account for 29% of the total budget; peer-reviewed members account for 100% of the use.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-25
Application #
6404915
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
1981-08-01
Project End
2004-11-30
Budget Start
Budget End
Support Year
25
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Knott, Simon R V; Wagenblast, Elvin; Khan, Showkhin et al. (2018) Erratum: Asparagine bioavailability governs metastasis in a model of breast cancer. Nature 556:135
Anderson, Chelsea; Smitherman, Andrew B; Nichols, Hazel B (2018) Conditional relative survival among long-term survivors of adolescent and young adult cancers. Cancer 124:3037-3043
Liu, Meng-Xi; Jin, Lei; Sun, Si-Jia et al. (2018) Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma. Oncogene 37:1637-1653
Curtis 2nd, Alan D; Jensen, Kara; Van Rompay, Koen K A et al. (2018) A simultaneous oral and intramuscular prime/sublingual boost with a DNA/Modified Vaccinia Ankara viral vector-based vaccine induces simian immunodeficiency virus-specific systemic and mucosal immune responses in juvenile rhesus macaques. J Med Primatol 47:288-297
Williams, Lindsay A; Nichols, Hazel B; Hoadley, Katherine A et al. (2018) Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study. Cancer Causes Control 29:25-32
Amunugama, Ravindra; Willcox, Smaranda; Wu, R Alex et al. (2018) Replication Fork Reversal during DNA Interstrand Crosslink Repair Requires CMG Unloading. Cell Rep 23:3419-3428
Little, Michael S; Pellock, Samuel J; Walton, William G et al. (2018) Structural basis for the regulation of ?-glucuronidase expression by human gut Enterobacteriaceae. Proc Natl Acad Sci U S A 115:E152-E161
Sin, Sang-Hoon; Eason, Anthony B; Bigi, Rachele et al. (2018) Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Renders B Cells Hyperresponsive to Secondary Infections. J Virol 92:
Dellon, Evan S; Selitsky, Sara R; Genta, Robert M et al. (2018) Gene expression-phenotype associations in adults with eosinophilic esophagitis. Dig Liver Dis 50:804-811
Rojas, Juan D; Lin, Fanglue; Chiang, Yun-Chen et al. (2018) Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy. Theranostics 8:141-155

Showing the most recent 10 out of 1525 publications